Aspirin Resistance: It’s Not One Size Fits All
Description: Jeff Boone, MD, Medical Director for the Boone Heart Institute in Denver, CO, describes aspirin resistance and related clinical studies, and how an assay can be used to determine the effectiveness of and appropriate dosing for patients undergoing aspirin anticoagulation therapy. ASCLS P.A.C.E. credits through April 12, 2012.
• Describe aspirin resistance and why a daily, 81 mg dose of aspirin may not have the same effect for every patient
• Discuss the significance and clinical implications of high levels of urinary thromboxane levels among patients undergoing aspirin therapy
• Choose appropriate actions for patients with high urinary thromboxane to improve clinical outcomes